Device trials in heart failure: A focused summary

Olaf Hedrich, Jonathan Weinstock, Mark Link, Munther Homoud, Mark Estes

Research output: Contribution to journalArticle

Abstract

Despite considerable progress in heart failure management with pharmacologic agents, measures to bring about significant improvements in morbidity and mortality are still needed. Cardiac resynchronization therapy (CRT) is a means to enhance myocardial function by stimulating the failing left ventricle at or near the time of right ventricular activation to synchronize ventricular depolarization. Current data from randomized, controlled trials suggest that CRT benefits patients with moderate to severe heart failure and have shown that this therapy significantly reduces mortality and hospital admissions in this group. In addition to CRT, implantable cardioverter-defibrillators have been evaluated in heart failure patients with significantly reduced left ventricular function and have been shown to reduce mortality from sudden cardiac death. This article summarizes recent device trials and discusses how best to apply their results to clinical practice.

Original languageEnglish (US)
JournalReviews in Cardiovascular Medicine
Volume6
Issue numberSUPPL. 2
StatePublished - Jun 1 2005

Fingerprint

Cardiac Resynchronization Therapy
Heart Failure
Equipment and Supplies
Mortality
Implantable Defibrillators
Sudden Cardiac Death
Hospital Mortality
Left Ventricular Function
Heart Ventricles
Randomized Controlled Trials
Morbidity
Therapeutics

Keywords

  • Biventricular pacing
  • Cardiac resynchronization therapy
  • Heart failure

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Hedrich, O., Weinstock, J., Link, M., Homoud, M., & Estes, M. (2005). Device trials in heart failure: A focused summary. Reviews in Cardiovascular Medicine, 6(SUPPL. 2).

Device trials in heart failure : A focused summary. / Hedrich, Olaf; Weinstock, Jonathan; Link, Mark; Homoud, Munther; Estes, Mark.

In: Reviews in Cardiovascular Medicine, Vol. 6, No. SUPPL. 2, 01.06.2005.

Research output: Contribution to journalArticle

Hedrich, O, Weinstock, J, Link, M, Homoud, M & Estes, M 2005, 'Device trials in heart failure: A focused summary', Reviews in Cardiovascular Medicine, vol. 6, no. SUPPL. 2.
Hedrich O, Weinstock J, Link M, Homoud M, Estes M. Device trials in heart failure: A focused summary. Reviews in Cardiovascular Medicine. 2005 Jun 1;6(SUPPL. 2).
Hedrich, Olaf ; Weinstock, Jonathan ; Link, Mark ; Homoud, Munther ; Estes, Mark. / Device trials in heart failure : A focused summary. In: Reviews in Cardiovascular Medicine. 2005 ; Vol. 6, No. SUPPL. 2.
@article{d56d12e777e74e7fa57e63a9e4508a3b,
title = "Device trials in heart failure: A focused summary",
abstract = "Despite considerable progress in heart failure management with pharmacologic agents, measures to bring about significant improvements in morbidity and mortality are still needed. Cardiac resynchronization therapy (CRT) is a means to enhance myocardial function by stimulating the failing left ventricle at or near the time of right ventricular activation to synchronize ventricular depolarization. Current data from randomized, controlled trials suggest that CRT benefits patients with moderate to severe heart failure and have shown that this therapy significantly reduces mortality and hospital admissions in this group. In addition to CRT, implantable cardioverter-defibrillators have been evaluated in heart failure patients with significantly reduced left ventricular function and have been shown to reduce mortality from sudden cardiac death. This article summarizes recent device trials and discusses how best to apply their results to clinical practice.",
keywords = "Biventricular pacing, Cardiac resynchronization therapy, Heart failure",
author = "Olaf Hedrich and Jonathan Weinstock and Mark Link and Munther Homoud and Mark Estes",
year = "2005",
month = "6",
day = "1",
language = "English (US)",
volume = "6",
journal = "Reviews in Cardiovascular Medicine",
issn = "1530-6550",
publisher = "MedReviews LLC",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Device trials in heart failure

T2 - A focused summary

AU - Hedrich, Olaf

AU - Weinstock, Jonathan

AU - Link, Mark

AU - Homoud, Munther

AU - Estes, Mark

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Despite considerable progress in heart failure management with pharmacologic agents, measures to bring about significant improvements in morbidity and mortality are still needed. Cardiac resynchronization therapy (CRT) is a means to enhance myocardial function by stimulating the failing left ventricle at or near the time of right ventricular activation to synchronize ventricular depolarization. Current data from randomized, controlled trials suggest that CRT benefits patients with moderate to severe heart failure and have shown that this therapy significantly reduces mortality and hospital admissions in this group. In addition to CRT, implantable cardioverter-defibrillators have been evaluated in heart failure patients with significantly reduced left ventricular function and have been shown to reduce mortality from sudden cardiac death. This article summarizes recent device trials and discusses how best to apply their results to clinical practice.

AB - Despite considerable progress in heart failure management with pharmacologic agents, measures to bring about significant improvements in morbidity and mortality are still needed. Cardiac resynchronization therapy (CRT) is a means to enhance myocardial function by stimulating the failing left ventricle at or near the time of right ventricular activation to synchronize ventricular depolarization. Current data from randomized, controlled trials suggest that CRT benefits patients with moderate to severe heart failure and have shown that this therapy significantly reduces mortality and hospital admissions in this group. In addition to CRT, implantable cardioverter-defibrillators have been evaluated in heart failure patients with significantly reduced left ventricular function and have been shown to reduce mortality from sudden cardiac death. This article summarizes recent device trials and discusses how best to apply their results to clinical practice.

KW - Biventricular pacing

KW - Cardiac resynchronization therapy

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=18944374994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18944374994&partnerID=8YFLogxK

M3 - Article

C2 - 15891701

AN - SCOPUS:18944374994

VL - 6

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

SN - 1530-6550

IS - SUPPL. 2

ER -